Biotechnology's Role In Combating Antibiotic Resistance And Safeguarding Public Health

Article Sidebar

pdf
Published: Jan 2, 2024
DOI: https://doi.org/10.53555/jaz.v44i5.3159
Keywords:
Antibiotic resistance, Biotechnology, Phage therapy, CRISPR-Cas, Synthetic biology, Diagnostics, Probiotics, Microbiome modulation, Public health

Main Article Content

Prof. Dr. Pratik Rajan Mungekar

Abstract

Antibiotic resistance poses a significant threat to public health, rendering once-effective antibiotics ineffective against bacterial infections. The rise of multidrug-resistant pathogens necessitates innovative approaches to combat this global crisis. Biotechnology, with its diverse tools and techniques, emerges as a crucial player in addressing antibiotic resistance. This research article explores the multifaceted role of biotechnology in combating antibiotic resistance and safeguarding public health

Downloads

Download data is not yet available.

Article Details

How to Cite
Prof. Dr. Pratik Rajan Mungekar. (2024). Biotechnology’s Role In Combating Antibiotic Resistance And Safeguarding Public Health. Journal of Advanced Zoology, 45(1), 278–286. https://doi.org/10.53555/jaz.v44i5.3159
Issue
Vol. 45 No. 1 (2024): Continuous Publication
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biography

Prof. Dr. Pratik Rajan Mungekar

Scientist, Distinguished Professor & Dean At Ccol London

References

Abedon, S. T. (2017). Phage therapy: Various perspectives on how to improve the art. Frontiers in Microbiology, 8, 180.

Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.

Gibson, D. G., Glass, J. I., Lartigue, C., Noskov, V. N., Chuang, R. Y., Algire, M. A., ... & Venter, J. C. (2010). Creation of a bacterial cell controlled by a chemically synthesized genome. Science, 329(5987), 52-56.

Honda, K., & Littman, D. R. (2016). The microbiome in infectious disease and inflammation. Annual Review of Immunology, 30, 759-795.

Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J. H., Chinwalla, A. T., ... & White, O. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207-214.

Landers, T. F., Cohen, B., Wittum, T. E., & Larson, E. L. (2012). A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Reports, 127(1), 4-22.

Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F., Sumpradit, N., ... & Cars, O. (2013). Antibiotic resistance—the need for global solutions. The Lancet Infectious Diseases, 13(12), 1057-1098.

Lehtinen, M. J., Hibberd, A. A., Männikkö, S., Yeung, N., Kauko, T., Forssten, S., ... & Ouwehand, A. C. (2013). Probiotic intervention modulates the inflammatory response and improves clinical outcomes in experimental pneumococcal meningitis. BMC Infectious Diseases, 13(1), 1-14.

Piddock, L. J. (2012). The crisis of no new antibiotics—what is the way forward?. The Lancet Infectious Diseases, 12(3), 249-253.

Sommer, M. O., Munck, C., Toft-Kehler, R. V., & Andersson, D. I. (2017). Prediction of antibiotic resistance: time for a new preclinical paradigm?. Nature Reviews Microbiology, 15(11), 689-696.

Theuretzbacher, U., Piddock, L. J., Non-Committee, T., & Society, B. S. (2019). Resistance drives antibacterial drug discovery. Antibiotics, 8(4), 179.

World Health Organization. (2015). Global action plan on antimicrobial resistance. Retrieved from https://www.who.int/antimicrobial-resistance/global-action-plan/en/